Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

193.03
-1.4000-0.72%
Post-market: 193.030.00000.00%19:16 EST
Volume:515.16K
Turnover:99.55M
Market Cap:9.50B
PE:-115.67
High:195.51
Open:194.37
Low:192.09
Close:194.43
52wk High:199.66
52wk Low:91.86
Shares:49.22M
Float Shares:48.62M
Volume Ratio:0.59
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6688
EPS(LYR):0.2004
ROE:-2.19%
ROA:4.33%
PB:2.79
PE(LYR):963.19

Loading ...

Charles River Laboratories International Inc. Stock Rises 4.8%, Outperforms Peers

Dow Jones
·
Dec 11

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 09

Charles River Laboratories International Inc. Stock Rises 5.7%, Outperforms Peers

Dow Jones
·
Dec 04

Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say

Benzinga_recent_news
·
Dec 04

BRIEF-Charles River Laboratories International Inc - Dsa Net Book-To-Bill Improved Each Month Since Q3 2025 - SEC Filing

Reuters
·
Dec 03

Charles River Laboratories International- Seasonality During Holiday Periods in Q4 and in Early Jan May Impact Near-Term Proposal, Booking Activity

THOMSON REUTERS
·
Dec 03

Charles River Laboratories Presents at Evercore 8th Annual Healthcare Conference

Reuters
·
Dec 03

Jefferies Adjusts PT on Charles River Laboratories International to $205 From $200, Maintains Buy Rating

MT Newswires Live
·
Dec 02

U.S. RESEARCH ROUNDUP- Green Brick Partners, Pultegroup, Toll Brothers

Reuters
·
Dec 02

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 02

Charles River Laboratories to Present at Evercore Healthcare Conference

Reuters
·
Dec 01

Charles River Laboratories International Inc. Stock Rises 4.5%, Outperforms Peers

Dow Jones
·
Nov 26

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 22

Charles River Q3 Adjusted EPS USD 2.43 Vs. IBES Estimate USD 2.34

Reuters
·
Nov 20

Charles River Exec Says Co Is Looking to Expand Its Services Portfolio in China - Jefferies Healthcare Conf

THOMSON REUTERS
·
Nov 18

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 18

Argus Upgrades Charles River Laboratories International to Buy From Hold, Price Target is $200

MT Newswires Live
·
Nov 17

Charles River: SEC concluded inquiry into company, not recommeding enforcement

TIPRANKS
·
Nov 17

SEC Ends Probe Into Charles River Laboratories With No Enforcement Action

Reuters
·
Nov 17

Charles River Laboratories-Investigation Was About Inquiry Requesting to Give Information Related to Sourcing Non-Human Primates & Related Disclosures

THOMSON REUTERS
·
Nov 17